Thursday, October 4, 2012

Is it a Question of Oversight?


In a Drug Linked to a Deadly Meningitis Outbreak, a Question of Oversight
The growing outbreak of meningitis was a calamity waiting to happen — the result of a lightly regulated type of drug production that had a troubled past colliding with a popular treatment.http://www.nytimes.com/2012/10/05/health/news-analysis-a-question-of-oversight-on-compounding-pharmacies.html?smid=pl-share

No comments: